Global Bio Identical Hormone Replacement Market Overview
Bio-Identical Hormone Replacement Market are biochemically engineered hormones that resemble hormones produced by the human body through natural biological processes. Estrogen, progesterone and testosterone are some of the common hormones that are manufactured artificially. Levels of hormones such as estrogen, progesterone and testosterone in the body are lowered with progression in age, which leads to certain menopausal symptoms in females such as hot flashes, weight gain, and vaginal pain due to sexual intercourse, vaginal dryness, night sweats, mood swings. In men, low testosterone level can cause erectile dysfunction and reduced bone density. Bio-identical hormones are used to treat men and women whose natural hormones levels are low or imbalanced. The FDA has approved the first bioidentical hormone therapy combination of estradiol and progesterone for moderate to severe vasomotor symptoms associated with menopause, TherapeuticsMD announced in a press release. The approval of the bioidentical estradiol and progesterone capsules (Bijuva), follows results from the phase 3 REPLENISH trial, first presented at the Endocrine Society annual meeting in April 2017 and reported by Endocrine Today, which demonstrated that a combination of 17beta-estradiol and progesterone appears to be safe and effective for reducing hot flash frequency and severity in menopausal women with a uterus. The approval of Bijuva represents an important and new opportunity for menopausal women suffering from moderate to severe vasomotor symptoms.
Global Bio Identical Hormone Replacement Market Dynamics
Rise in the number of menopausal women
Menopause is a routine, non-pathologic condition involving the permanent cessation of menses for at least 12 months. Menopause occurs in all menstruating females due to non-pathologic estrogen deficiency. The median age of menopause is 51. Most women experience vasomotor symptoms, but menopause can affect many areas, some of which are the urogenital and cardiovascular systems. This activity reviews the presentation, evaluation, and management of menopause and stresses the role of an interprofessional team approach to care for affected individuals.
As of 2020, the majority of women across the globe started going through perimenopause (which usually lasts 3 to 5 years before menstruation totally stops and menopause begins) at around 45 to 50 years of age.
Increasing awareness on post-menopausal hazards
In celebration of the 25th anniversary of The North American Menopause Society (NAMS), the Society has compiled a set of key points and clinical recommendations for the care of midlife women. NAMS has always been a premier source of information about menopause for both healthcare providers and midlife women. At this special time in the history of the Society, we wished to provide a succinct guide to improve the understanding and management of women_s health at this critical stage of life. In addition to covering the key topics of vasomotor symptoms, osteoporosis, and vulvovaginal health, this guide includes information and recommendations for care on more than 50 important topics, including sexual function, cognition, cardiovascular health, thyroid disease, and cancers. Additional sections review basic physiology, counseling issues, screening tests, and complementary and alternative medicine
Increase in adoption of anti-aging therapy and newer formulations
In recent years, compounded bioidentical hormone therapy (CBHT) has emerged as a popular alternative to manufactured, FDA approved hormone therapy (HT)—despite concerns within the medical community and the availability of new FDA approved “bioidentical” products. Divigel(R) (Estradiol Gel) 0.1% is One of a Newer Generation of Bioidentical Estrogens That is FDA-Approved for Relief of Hot Flashes, Including Night Sweats, From Menopause. Women looking for the best method to manage common symptoms of menopause, like hot flashes and night sweats, may not have access to credible information, especially when it comes to understanding their estrogen therapy options. In fact, there are an array of celebrities and authors who are simply not qualified to give medical advice about managing menopause, yet they dominate the internet and media space simply because of their popularity. Many medical experts believe that the influence of these non-medical professionals has been an obstacle to women learning about the newer generation of bioidentical estrogens that are FDA-approved.
Global Bio Identical Hormone Replacement Market Segmentation
The Global Bio-identical hormone replacement market is segmented based on Type, Product Type, End-User and region.
On the basis of type market is segmented into Estrogens, Progesterone, Testosterone, Others. On the basis of Product Type market is segmented into Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, Others. On the basis of End-Users market is segmented into Hospitals, Academic and Research, Others. On the basis of Region market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.
Regional Insights:
On region the Global Bio-identical hormone replacement market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America Bio-Identical Hormone Replacement Market garnered a revenue of USD 2630.0 Million in the year 2019 globally and has been foreseen to yield USD 4330.5 Million by the year 2029 at a compound annual growth (CAGR) of 5.1% over the forecast period.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Type: Estrogens, Progesterone, Testosterone, Others By Product Type: Tablets and Capsules, Creams and Gels, Injectable, Patches and Implants, Others By End-Users: Hospitals, Academic and Research, Others |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Bio-identical Hormone Replacement Market report based on product, site of collection, application, and region.
Global Bio-identical Hormone Replacement Market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Bio Identical Hormone Replacement Market Key Players
The key players operating in the Global Bio-identical hormone replacement market includes SottoPelle, Therapeutic MD, BioTE Medical, Neuva Aesthetics, Biostation, Defy Medical, and Full Life Wellness. As the COVID-19 situation evolves, TherapeuticsMD is providing the update on its business operations. At this time, TherapeuticsMD continues to provide an uninterrupted supply of their portfolio of products for patients. They have activated virtual options to ensure business continuity. In addition, they have taken action to support the health of their employees. While they cannot predict the extent to which COVID-19 will continue to spread and how it will impact society and our business, they will continue to do all that we can to meet the needs of their patients and providers.
Global Bio Identical Hormone Replacement Market Company Profile
- SottoPelle
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Therapeutic MD
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- BioTE Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Neuva Aesthetics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Biostation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Defy Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Full Life Wellness
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
Global Bio Identical Hormone Replacement Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Bio-identical hormone replacement Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Product Type
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Bio-identical Hormone Replacement Market, By Type, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Estrogen
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Progesterone
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Testosterone
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Bio-identical Hormone Replacement Market, By Product Type, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Capsules & Tablets
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Cream & Gels
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Injectables
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Patches & Implants
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Bio-identical Hormone Replacement Market, By End-User, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Academics & Research
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
- Overview
- Global Bio-identical Hormone Replacement Market, By Region, 2020 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
- Y-o-Y Growth Analysis (%), 2020 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2029
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- SottoPelle
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Therapeutic MD
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- BioTE Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Neuva Aesthetics
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Biostation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Defy Medical
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Full Life Wellness
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
The Global Bio-identical hormone replacement market is segmented based on Type, Product Type, End-User and region.
Rise in the number of menopausal women to Boost is the major factor driving growth of the global bio-identical hormone replacement market
On region the Global Bio-identical hormone replacement market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America Bio-Identical Hormone Replacement Market garnered a revenue of USD 2630.0 Million in the year 2019 globally and has been foreseen to yield USD 4330.5 Million by the year 2029 at a compound annual growth (CAGR) of 5.1% over the forecast period.
The key players operating in the Global Bio-identical hormone replacement market includes SottoPelle, Therapeutic MD, BioTE Medical, Neuva Aesthetics, Biostation, Defy Medical, and Full Life Wellness.